Amparo, a U.S.-based company specializing in lower limb prosthetics, has acquired Portuguese startup Adapttech, known for integrating AI-driven solutions into prosthetic care. The deal, for which the value was undisclosed, marks an expansion into 40 countries, with a strong focus on the Middle East and Asia.
Key Takeaways from the Acquisition:
- Team Integration: Adapttech’s entire team has been incorporated into Amparo.
- Leadership Changes:
- Frederico Carpinteiro, former CEO of Adapttech, is now CEO of Amparo.
- Wesley Teerlink shifts from Amparo's CEO role to CTO, focusing on innovation.
- Stuart Mead remains as Chairman.
- Diogo Lopes takes over as CMO.
- Technology & Product Innovation:
- The company will combine Amparo’s physical prosthetic fittings with Adapttech’s data-driven insights, improving patient care.
- Their Motio StepWatch device will continue providing clinical teams with real-time patient activity data.
- Expansion Goals:
- Strengthening presence in Middle Eastern & Asian markets.
- Enhancing product offerings, including the first pediatric prosthetic socket, developed in response to the growing need in Gaza.
- Continuing humanitarian efforts, such as the “Restoring Hope” initiative, which has already provided 300 people in Gaza with prosthetics since September 2024.
This acquisition highlights a growing trend of AI-driven healthcare solutions and further solidifies Portugal's role as a hub for healthtech innovation.
Related News